top of page
Research Articles

      Abstract    

        

HOME

CLINICOHEMATOLOGICAL PROFILES OF HEPATITIS C VIRUS (HCV): A RETROSPECTIVE HOSPITAL BASED STUDY

 

Jakribettu RP, George T, Rai MP, Sajan S, Challapalli A, Mathew JM, Baliga MS

​

ABSTRACT:Aim: Acute viral hepatitis C (HAC) is an important organ specific virus affecting the liver. The pathological sequelae of the infection are well documented and a detailed literature study indicates that most studies have been on liver the primary organ affected by HCV. Studies and observations on the effect of HCV on the extrahepatic organs are lacking. The present study was carried out to ascertain clinical presentations and the alterations on the haematological and hepatic parameters. Material and Methods: This was a retrospective study and was conducted in a tertiary care hospital in India. Data was collected and analysed in people who were confirmed to be affected only by HCV by the standard diagnostic method using the Anti HCV Antibody for the period January 2014 to June 2016. A total of 48 people were included in the study and compared with healthy individuals who were tested negative for any infectious and chronic diseases (annual health check up individuals). Results: The results indicated that during the study period, 48 individuals were tested positive for HCV. Of these, 35 were symptomatic, while 13 were asymptomatic and were diagnosed incidentally during routine/mandatory investigation before surgery. In the 35 symptomatic patients jaundice (82.85%) and loss of appetite (57.14%) were the two predominant clinical symptoms. There was a significant difference in the various haematological, hepatic and electrolyte endpoints (p < 0.05 to 0.0001).  Conclusion: The study indicates that acute infection with HCV causes changes in the alterations in haematological, hepatic and electrolytes in the serum.

​

KEY WORDS: Hepatitis C Virus (HCV); clinical, haematological, electrolytes.

​

REFERENCES:

  1. Khaliq S, Jahan S, Hassan S. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target. Liver Int. 2011; 31(5):606-17.

  2. Anoynomous. Editorial: Non-A, non-B. Lancet 1975; 2: 64-65.

  3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.

  4. Vieyres G, Thomas X, Descamps V, Duverlie G, Patel AH, Dubuisson J. Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J Virol. 2010; 84:10159-68.

  5. World Health Organization Hepatitis C Fact Sheet 2017.

  6. World Health Organization Hepatitis C Fact Sheet 2012.

  7. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 2008; 47: 1128-1135.

  8. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899-1905.

  9. Van der Poel CL, Reesink HW, Lelie PN, Leentvaar-Kuypers A, Choo QL, Kuo G, Houghton M. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet. 1989; 2(8658):297–298.

  10. Bukh J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. ProcNatlAcadSci USA 1992; 89: 187-191.

  11. Cha TA, Kolberg J, Irvine B, Stempien M, Beall E, Yano M, Choo QL, Houghton M, Kuo G, Han JH, et al. Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol. 1991; 29:2528–53.

  12. Chevaliez S, Rodriguez C, Pawlotsky JM. New virologic tools for management of chronic hepatitis B and C. Gastroenterology 2012; 142:1303-1313.

  13. Park Y, Lee JH, Kim BS, Kim do Y, Han KH, Kim HS. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J ClinMicrobiol 2010; 48: 2253-225.

  14. Hosseini-Moghaddam SM, Iran-Pour E, Rotstein C, Husain S, Lilly L, Renner E, Mazzulli T. Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up? Rev Med Virol 2012; 22: 156-165.

  15. Descamps V, Op de Beeck A, Plassart C, Brochot E, François C, Helle F, Adler M, Bourgeois N, Degré D, Duverlie G, Castelain S. Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients. J ClinMicrobiol 2012; 50: 465-68.

  16. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245-264.

  17. Centers for Disease Control and Prevention (CDC). Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 2013; 62: 362-365.

  18. Haber MM, West AB, Haber AD, et al. Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995;90:1250–7.

  19. Bonacini M, Hadi G, Govindarajan S, et al. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997; 92:1302–4.

  20. Giannini E, Botta F, Fasoli A, et al. Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci 1999; 44:1249–53.

  21. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998; 93(1):44-8.

  22. Reedy DW, Loo AT, Levine RA. AST/ALT ratio 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C. Dig Dis Sci 1998; 43:2156–9.

  23. Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 1988; 95:734–9.

  24. Sood A,Midha V, Sood N,Kaur H,Malhotra V, Awasthi G. Chronic Hepatitis C in Northern India – ThePathological and Clinical Spectrum. JAPI .2004, 52; 5:380-84.

  25. Fasola F A, Otegbayo J A, Abjah U M A and Ola S O. Haematological parameters in Nigerians with acute viral hepatitis. Nigerian Journal of Gastroenterology and Hepatology 2009; 1:27-31

  26. Alsaran K A, Sabry A A,Alghareeb A H and Al Sadoon G  Effect of Hepatitis C Virus on Hemoglobin and Hematocrit Levels in Saudi Hemodialysis Patients, Renal Failure. 2009; 31: 349-354,

  27. Asghar S, Zia M A, Jafri S A, Ahmed I and Amjad M.A Correlative Study Between Biochemical and Hematological Parameters and Hepatitis C Prevalence in the Premises of Faisalabad.Middle-East Journal of Scientific Research2011; 7: 538-42.

  28. Alsaran KA, Sabry AA, Alghareeb AH, Al Sadoon G. Effect of hepatitis C virus on hemoglobin and hematocrit levels in Saudi hemodialysis patients. Ren Fail. 2009; 31: 349-54.

 To cite this article:

Jakribettu RP, George T, Rai MP, Sajan S, Challapalli A, Mathew JM, Baliga MS; Clinicohematological profiles of hepatitis c virus (HCV): a retrospective hospital based study. Int. J. Med. Lab. Res. 2018, 3(2): 46-51

bottom of page